Company intelligence / Profile preview

CoreQuest

Santa Clara, California, United States

Ownership: Private
Development stage: Other

Overview

CoreQuest was a medical technology company focused on developing innovative percutaneous therapies for the treatment of heart failure. The company's primary focus was on a catheter-based system designed to improve cardiac function in patients suffering from chronic heart failure. By utilizing minimally invasive techniques, CoreQuest aimed to provide therapeutic alternatives to traditional surgical interventions. The company was acquired by Medtronic in 2000 to bolster its cardiovascular portfolio and integrate CoreQuest's heart failure therapy technologies into its existing product lines.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on CoreQuest.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CoreQuest.

Explore the full profile